Eisai
4523.T
#1543
Rank
NZ$18.47 B
Marketcap
$65.31
Share price
2.29%
Change (1 day)
-36.05%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total assets

Total assets on the balance sheet as of March 2024 : NZ$14.88 B

According to Eisai's latest financial reports the company's total assets are NZ$14.88 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Eisai - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-03-31NZ$15.14 B3.35%
2022-03-31NZ$14.65 B3.9%
2021-03-31NZ$14.10 B-14.95%
2020-03-31NZ$16.58 B16.84%
2019-03-31NZ$14.19 B4.13%
2018-03-31NZ$13.62 B3.65%
2017-03-31NZ$13.14 B4.83%
2016-03-31NZ$12.54 B7.36%
2015-03-31NZ$11.68 B6.91%
2014-03-31NZ$10.92 B-12.9%
2013-03-31NZ$12.54 B-15.05%
2012-03-31NZ$14.76 B-10.39%
2011-03-31NZ$16.48 B-0.73%
2010-03-31NZ$16.60 B-19.61%
2009-03-31NZ$20.65 B47.51%
2008-03-31NZ$14.00 B48.94%
2007-03-31NZ$9.40 B-10.34%
2006-03-31NZ$10.48 B20.3%
2005-03-31NZ$8.71 B-3.09%
2004-03-31NZ$8.99 B-0.69%
2003-03-31NZ$9.05 B-4.59%
2002-03-31NZ$9.49 B-13.13%
2001-03-31NZ$10.92 B